OAS2 and head and neck cancer: Of importance, the pattern of expression was different from patient E9, the nCounter analysis also identified OAS2 as well as another gene CXCR1, showing an increased expression in the head and neck cancer patient N5 at 5 weeks (Figures 4A,C).